Published: October 26, 2026 · 9:43 PM IST
Stock Updates › Corporate Actions
India – 26 October 2026 India – 26 October 2026 – Sakar Healthcare Limited (NSE: SAKAR) has submitted an investor presentation on its unaudited financial results for the quarter and half year ended September 30, 2026 to the exchange. The presentation shows consolidated Profit After Tax of Rs. 1,130.69 Lakhs for Q2 FY27.
Details & Regulatory Compliance
| Particulars | As stated in the filing |
|---|---|
| Subject | Presentation on the Unaudited Financial Results (Consolidated and Standalone) for the quarter and half year ended September 30, 2026 |
| Revenue from Operations (consolidated, Q2 FY27) | Rs. 8,741.61 Lakhs, 52% Y-o-Y |
| EBITDA (consolidated, Q2 FY27) | Rs. 2,434.53 Lakhs, 114% Y-o-Y |
| Profit After Tax (consolidated, Q2 FY27) | Rs. 1,130.69 Lakhs, 149% Y-o-Y |
| Revenue from Operations (consolidated, H1FY27) | Rs. 16,038.86 Lakhs, 45% Y-o-Y |
| EBITDA (consolidated, H1FY27) | Rs. 4,559.42 Lakhs, 90% Y-o-Y |
| Profit After Tax (consolidated, H1FY27) | Rs. 2,159.18 Lakhs, 134% Y-o-Y |
| Basic EPS (consolidated, Q2 FY27) | 5.08 |
| Oncology product contracts | 69 oncology product contracts executed; 45 commercial discussions currently underway |
| Dossiers and Marketing Authorisations | Shared 351 dossiers globally, of which 191 have been submitted and 22 have received Marketing Authorisations |
Share Price (Market Context)
Share price data is for context only. It is not part of the filing.
Understanding this filing
- Regulation 30
- The SEBI rule that requires listed companies to tell the stock exchanges promptly about important events such as major orders.
Plain-words guide by FinvestNews. General explanations, not part of the filing.
Authoritative Sources
This article is based exclusively on the corporate announcement filed by Sakar Healthcare Limited with the stock exchanges.
Regulation: Regulation 30 of SEBI (LODR) Regulations, 2015
Useful Websites for Investors
- BSE Ltd.: https://www.bseindia.com/
- National Stock Exchange of India Ltd.: https://www.nseindia.com/
- Securities and Exchange Board of India: https://www.sebi.gov.in/
Not a SEBI Registered Analyst
I/We am/are not a SEBI Registered Investment Adviser or Research Analyst. All information shared is for educational and informational purposes only and is not intended as a substitute for professional financial advice. All opinions expressed herein are based on my/our personal observations and research. They do not constitute a recommendation or a solicitation to buy, sell, or hold any security. Investments in the securities market are subject to market risks. The value of investments may go up or down. Past performance is not indicative of future results.
You are solely responsible for your own investment decisions. You should conduct your own research and consult with a qualified/certified financial advisor before making any investment based on the information provided here.
I/We may or may not hold positions in the securities mentioned here or anywhere in this website. I/We have no relationship/Sponsorship with/by the companies mentioned unless explicitly stated.
No sign-in and no comments. Your choices stay in this browser. The heart saves this topic.